Bank Of Nova Scotia Dexcom Inc Transaction History

Bank Of Nova Scotia

$52.2 Billion
Q4 2024

A detailed history of Bank Of Nova Scotia transactions in Dexcom Inc stock. As of the latest transaction made, Bank Of Nova Scotia holds 268,740 shares of DXCM stock, worth $20.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

268,740

Previous 173,863 54.57%

Holding current value

$20.2 Million

Previous $11.7 Million 79.36%

% of portfolio

0.04%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$65.68 - $81.01 $6.23 Million - $7.69 Million	94,877 Added 54.57%	268,740 $20.9 Million
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $2 Million - $3.64 Million	31,321 Added 21.97%	173,863 $11.7 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $3.73 Million - $4.75 Million	33,846 Added 31.14%	142,542 $16.2 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $2.99 Million - $3.67 Million	26,201 Added 31.76%	108,696 $15.1 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $5.16 Million - $8.49 Million	-68,400 Reduced 45.33%	82,495 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $3.2 Million - $5.13 Million	37,158 Added 32.67%	150,895 $14.1 Million
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $13.1 Million - $15.3 Million	-116,892 Reduced 50.68%	113,737 $14.6 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $21.1 Million - $24.9 Million	202,422 Added 717.63%	230,629 $26.8 Million
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $797,367 - $1.15 Million	9,383 Added 49.85%	28,207 $3.19 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $2.19 Million - $2.71 Million	-28,727 Reduced 60.41%	18,824 $1.52 Million
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $2.42 Million - $4.72 Million	35,530 Added 295.57%	47,551 $3.54 Million
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $614,248 - $850,075	-6,529 Reduced 35.2%	12,021 $6.15 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $517,402 - $648,674	3,984 Added 27.35%	18,550 $9.96 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $207,871 - $278,914	1,948 Added 15.44%	14,566 $7.97 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1.02 Million - $1.36 Million	12,618 New	12,618 $5.39 Million

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Dexcom Inc Transaction History